FibroBiologics is pursuing a development program for FSdC spheroids with the goal of advancing to clinical trials. The data includes comprehensive preclinical pharmacology and efficacy assessments ...

Have you noticed the other big story in college football this year? The big story is, of course, Indiana. It’s hard to get ...

Challenges remain, like regulatory hurdles and funding, but our team's grit and your support as shareholders make me ...

FBLG READ THE FULL FBLG RESEARCH REPORT Business Update Approval from HREC for Phase 1/2 Diabetic Foot Ulcer Trial In ...

FibroBiologics submits IND application with US FDA to initiate clinical trials of CYPS317 in psoriasis patients: Houston Saturday, January 3, 2026, 11:00 Hrs [IST] FibroBiologics ...

Learn 7 fascinating facts about Earth Rotation Day 2026 and understand how our planet’s spin affects time, seasons, and life ...

Detailed price information for Fibrobiologics Inc (FBLG-Q) from The Globe and Mail including charting and trades.

Undefeated, armed with the Heisman winner and a blueprint of dominance cribbed straight from Saban himself, Indiana is ready ...

Nearly every galaxy has a supermassive black hole in its core. Whether the black hole forms first and then the galaxy around ...

FibroBiologics (FBLG) announced preclinical results for FSdC, an investigational FSdC spheroid-based therapy, demonstrating superior improvement ...

FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development ...

Given the current state of practice and visions for the future (including AI), certain practices should be reevaluated. This ...